info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Dental Sleep Medicine Market Research Report – Forecast to 2027

Dental Sleep Medicine Market Information: by treatment & diagnostics (positive airway pressure (pap) therapy, oral and nasal devices, airway systems, other devices, drugs, surgery, polysomnography and polygraphy, oximetry and actigraph), by end users - forecast till 2027

ID: MRFR/MED/2220-CR | May 2017 | Region: Global | 83 pages

Dental Sleep Medicine Market Speak to Analyst Request a Free Sample

Dental Sleep Medicine Market Overview


According to a new research study, the global Dental Sleep Medicine Market size is predicted to grow at a rapid rate with a substantial CAGR during the forecast period. Dental sleep medicine is a branch of dentistry that treats sleep-related breathing disorders such as snoring, upper airway resistance syndrome (UARS), bruxism, and sleep apnea with oral appliances such as positive airway pressure (PAP) devices, nasal masks, and airway systems, as well as drugs such as Provigil (modafinil) and Nuvigil (armodafinil). The primary cause of the worldwide dental sleep medication market's rise is the rising prevalence of sleep apnea.
One of the major reasons driving the growth and demand of the dental sleep medicine market is the rapidly growing awareness of sleep disorders throughout the world. In addition, throughout the projected period of 2021 to 2028, the quick increase in illnesses and the growing elderly population are both contributing to the worldwide market's growth. Rapid technical advances and the rising incidence of sleep apnea throughout the world are also propelling the market forward. Furthermore, a growing awareness of the long-term consequences of obstructive sleep apnea is one of the major reasons fueling the expansion of the sleep dental medicine industry.
This report contains all the information on the global Dental Sleep Medicine Market and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global dental sleep medicine market growth value and forecast for 2023 is also included in the report.
Covid 19 Analysis
Coronavirus COVID-19's Impact: Since the emergence of the COVID-19 virus in December 2019, the disease has spread to nearly every country on the planet, prompting the World Health Organization to declare it a public health emergency. The global effects of the coronavirus illness 2019 (COVID-19) are already being felt, and the dental sleep medicine market trends will be substantially impacted in 2021. Flight cancellations, travel restrictions, and quarantines, restaurants closing, all indoor/outdoor events being limited, over forty nations declaring states of emergency, major supply chain slowdowns, and stock market volatility have all been impacted by the COVID-19 epidemic.
Market Dynamic


  • Drivers


During the assessment period, the worldwide dental sleep medicine market is expected to rise at a significant CAGR (2016-2022). According to a Market Research Future (MRFR) analysis, some of the market trends and factors in this market include the rising global prevalence of sleep apnea, unmet medical needs, a growing geriatric population, adoption of cutting-edge innovative technologies, and an increase in the prevalence of lifestyle-related diseases such as cardiovascular disease and obesity.


  • Opportunities


In the projection period of 2021 to 2028, the dental sleep medicine market will benefit from increased research and development, as well as linked solutions and cloud-based systems, as well as personalized and customized solutions.



  • Restraints


Some factors that may impede the growth of the dental sleep medicine market include a lack of patient awareness and expensive treatment prices.



  • Challenges


The high cost and scarcity of sleep laboratories, as well as their lack of efficacy and efficiency, would restrict the expansion of the dental sleep medicine market, whereas inadequate standardization, lack of knowledge, and discomfort may provide a challenge to the dental sleep medicine market's growth.


Cumulative Growth Analysis


Unmet medical demands are driving the growth of the dental sleep medication industry. Obstructive sleep apnea affects over 30 million individuals in the United States, according to the American Academy of Dental Sleep Medicine. Sleep is harmed by sedentary lifestyles, extended working hours, noise exposure, and light pollution such as the usage of bright neon lights. Due to its safety, efficiency, and efficacy when compared to procedures and medicines, positive air pressure treatment has the greatest dental sleep medicine market share.


The gold standard in dental sleep medicine diagnosis is polysomnography and respiratory polygraphy. However, because of their simplicity of use, efficiency, and accuracy, the emergence of portable and home-based devices is threatening their market dominance. The primary reason for the increase in efficiency and accuracy is the employment of sophisticated software in these products. Oximetry is more portable and quicker, but the findings are less sensitive and accurate.


Value Chain Analysis


According to the reports, the global dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. Positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices are all part of the treatment section. Polysomnography and respiratory polygraphy, home oximetry, and actigraphy are all part of the diagnostics section. The dental sleep medicine market is divided into three categories based on the end-user: hospitals, sleep labs, and homes. In 2016, the treatment segment had the biggest dental sleep medicine global market share of 61.42 percent, and it is anticipated to increase at a CAGR of 8.74 percent from 2016 to 2022. In 2016, hospitals and sleep laboratories had the biggest dental sleep medicine global market share of 57.1 percent, while North America had the largest market share of USD 2,849.44 million.


Dental sleep medicine global market, by region 2016 & 2023 (market value) Dental sleep medicine market, by Region 2016


Segmentation Overview


The dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. The global dental sleep medicine market is expected to witness decent growth during the forecast period.


By Application


Based on the application, the dental sleep medicine market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices.


By end-users


Based on the propulsion types, the dental sleep medicine market is segmented into hospitals, sleep labs, and homes.


Regional Analysis


According to the reports, on the basis of region, the global dental sleep medicine market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America was the world's largest market for dental sleep medicine. Because of its high per capita income, superior reimbursement policies for medical equipment, and larger healthcare industry, the United States leads the North American market. The expansion of the North American market is also fueled by the concentration of major medical device makers in the United States. In 2016, Europe was the world's second-largest market for dental sleep medicine. The emerging regions, notably the Asia Pacific and the Middle East, and Africa, are projected to see the greatest growth for high-tech and low-tech dental sleep medication products throughout the projection period due to huge unmet demand.


Competitive landscape


The global dental sleep medicine market is highly fragmented due to the presence of prominent players in the market. Mergers, R&D, partnerships, and other tactics used by market players to get a foothold in this Market organizations are examples of specific methods used by market players to gain a foothold in the Dental Sleep Medicine Market.


Major Key Players



  •         Koninklijke Philips N.V.

  •         ResMed

  •         Fisher & Paykel Healthcare

  •         Drive DeVilbiss Healthcare

  •         Curative Medical Inc.

  •         Apex Medical Corporation

  •         BMC Medical Co. Ltd.

  •         Becton, Dickinson and Company

  •         others.


Report Overview


The following report comprises of –



  •         Market overview 

  •         Covid 19 Analysis

  •         Market Dynamic

  •         Drivers

  •         Opportunities

  •         Restraints 

  •         Challenges

  •         Cumulative Growth Analysis

  •         Value Chain Analysis

  •         Segmentation Overview 

  •         By Application 

  •         By End-Users

  •         Regional Analysis

  •         Competitive landscape


 Recent Developments
2018, April- The American Academy of Dental Sleep Medicine, a leading national dentists' organization, has announced the AADSM Mastery Program, which will ensure that dentists have the necessary skills and training to provide patients with sleep-related breathing disorders such as snoring and obstructive sleep apnea (OSA) with proper oral appliance therapy (OAT).

Market Segmentation


 By Treatment & Diagnostics



  • Positive Airway Pressure (Pap) Therapy

  • Oral And Nasal Devices

  • Airway Systems

  • Other Devices,

  • Drugs,

  • Surgery,

  • Polysomnography And Polygraphy,

  • Oximetry

  • Actigraph


By End User



  • Home,

  • Sleep Laboratories

  • Hospitals


By Geography



  • North America


    • US

    • Canada


  • Europe


    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • LAMEA


    • Brazil

    • Saudi Arabia

    • UAE

    • Rest of LAMEA





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2016-2022: 8.74 %
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Treatment, Diagnostics and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company
  Key Market Opportunities

  • The North American market is led by the U.S. due to high per capita income, better reimbursement policy for medical devices, and larger healthcare market
  • Concentration of major medical device manufacturers in the U.S.
  • Fastest growth for high-tech and low-tech dental sleep medicine products in Asia Pacific and the Middle East & Africa
  •   Key Market Drivers   Unmet medical needs and rising prevalence of sleep apnea


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    North America is predicted to lead the Dental Sleep Medicine Market.

    Sleep laboratories and hospitals will dominate the Dental Sleep Medicine Market.

    Unmet medical needs and rising prevalence of sleep apnea are boosting market growth.

    Specific strategies adopted by market players to create a foothold in the Dental Sleep Medicine Market include mergers, R&D, collaborations, and others.